Baker Neuropsychology
Jason J. Baker, Ph.D.
Phone: (602) 274 - 1462 | Fax: (602) 274 - 7402 | Email: jasonbaker@bakerneuropsychology.com
Research on Neurofeedback
Clients or parents interested in learning more about qEEG assessment and Neurofeedback
can download and read the following articles from scientific journals which describe the
potential benefits associated with qEEG-Guided Neurofeedback.
Neurofeedback for ADHD
Article on the Lasting Effects of
Neurofeedback for
ADHD
Article on the Efficacy of
Neurofeedback for ADHD
Over the past 20+ years, numerous studies have supported the benefits of
Neurofeedback for various conditions, including ADHD. In fact, Neuroguide (the program
we use) achieved FDA approval in 2003 for functions related to ADHD and Traumatic
Brain Injury. The use of qEEG technology lies at the root of Neurofeedback technology
and is now being used all over the world as a treatment approach for ADHD and other
problems and disorders. Neurofeedback has even become reimbursable through
insurance companies under certain circumstances for certain type of conditions. We can
provide clients with a superbill to submit to their insurance.

Four randomized controlled trials have shown Neurofeedback to be superior to a
(semiactive) control group, whereby the requirements for Level 4: Efficacious are fulfilled
(Criteria for evaluating the level of evidence for efficacy established by the AAPB and
ISNR). In line with the AAPB and ISNR guidelines for rating clinical efficacy, both
prospective controlled studies and studies employing a pre- and post-design concluded
Neurofeedback treatment for ADHD was considered ‘Efficacious and Specific’ (Level 5)
with a large Effect Size (ES) for inattention and impulsivity, and a medium ES for
hyperactivity. These results are consistent with meta-analytic research showing that
Neurofeedback is equal or superior to stimulant medication in the treatment of
inattention and impulsivity. The effects of Neurofeedback have been found to persist up
to 9 years or longer (after Neurofeedback treatment was ended). As noted in an article
below from the official journal of the American Academy of Pediatrics ("Pediatrics"), a
recent study found that students with ADHD maintained almost all behavioral gains from
Neurofeedback six months after treatment was stopped, whereas students who instead
received computerized interventions for attention only maintained a small portion of
treatment improvements. The minimal potential for side-effects of Neurofeedback
treatment (in comparison to medication) result in many clients and/or parents choosing
Neurofeedback instead of medication for the treatment of inattention and
hyperactivity/impulsivity. It is also possible to use both medication and Neurofeedback
in the treatment of symptoms associated with ADHD.

As described in an article (see below) by Hammond (2011), peer-reviewed and scientific
research has strongly supported the use of Neurofeedback with ADHD, learning
disabilities (e.g., reading disorder/dyslexia), autism-spectrum disorders, neurological
disorders (e.g., traumatic brain injury and stroke), anxiety (e.g., Generalized Anxiety
Disorder and OCD), posttraumatic stress disorder (PTSD), migraine headaches, chronic
pain, sleep disturbance, alcohol and substance abuse, and depression. Neurofeedback
has also been used successfully in optimizing peak performance in athletes, musicians,
and surgeons.
Additional Links and Resources
Article on what is Neurofeedback?
Video on the Evidence Supporting
Neurofeedback for ADHD
Video on Neurofeedback for Autism

Baker Neuropsychology
Jason J. Baker, Ph.D.
Phone: (602) 274 - 1462 | Fax: (602) 274 - 7402 | Email: jasonbaker@bakerneuropsychology.com


1515 E. Missouri Ave. Suite #110
Phoenix, Arizona 85014

Baker Neuropsychology
Jason J. Baker, Ph.D.
Phone: (602) 274 - 1462 | Fax: (602) 274 - 7402 | Email: jasonbaker@bakerneuropsychology.com